Literature DB >> 6339822

Detection and quantitation of 3 alpha-hydroxy-1-methylen-5 alpha-androstan-17-one, the major urinary metabolite of methenolone acetate (Primobolan) by isotope dilution--mass spectrometry.

I Björkhem, H Ek.   

Abstract

A highly accurate method has been developed for detection and quantitation of 3 alpha-hydroxy-1-methylen-5 alpha-androstan-17-one, the major urinary metabolite of methenolone acetate (Primobolan) in man. Unlabelled as well as 2H-labelled 3 alpha-hydroxy-1-methylen-5 alpha-androstan-17-one were synthesized from 1-methylen-5 alpha-androstane-3,17-dione. A fixed amount of the internal standard was added to a fixed amount of urine and the mixture was treated with Helix pomatia for 24 h. After extraction and purification by t.l.c., the mixture was converted into methoxime--trimethylsilyl derivative and analyzed by combined GC--MS. Unlabelled 3 alpha-hydroxy-1-methylen-5 alpha-androstan-17-one could be quantitated from the ratio between the tracings of the ions at m/z 372 and m/z 375 (corresponding to the M-31 ions). In alternative procedures, the ions at m/z 403 and m/z 406 (molecular ions) as well as m/z 282 and m/z 285 (M-90-31 ions) could be used. Under the conditions employed, the metabolite could be identified and quantitated in concentrations exceeding 10 ng/ml. Significant amounts of the metabolite could be detected in urine during 5 days after a single oral ingestion of 10 mg of Primobolan. The method has been successfully used for analyses of urine samples obtained from athletes involved in competition.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6339822     DOI: 10.1016/0022-4731(83)90069-9

Source DB:  PubMed          Journal:  J Steroid Biochem        ISSN: 0022-4731            Impact factor:   4.292


  1 in total

1.  Metabolism of methenolone acetate in a veal calf.

Authors:  N Van Hoof; D Courtheyn; W Gillis; J Van Hende; C Van Peteghem; M Van de Wiele; S Poelmans; H Noppe; C Van Poucke; E Cobbaert; P Vanthemse; H F De Brabander
Journal:  Vet Res Commun       Date:  2006-12-23       Impact factor: 2.459

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.